There is optimism that the Royal Commission into Aged Care Quality and Safety can stimulate real change beyond words, writes DTA Executive Director, Professor Belinda Goodenough, for the Australian Journal of Dementia Care.
DTA’s Medication Management Consultancy has seen as much as a 60% relative reduction in antipsychotic medications prescribed within residential aged care facilities across Australia.
The Fellowship programs at DTA all have a common theme – to place the wellbeing of people living with dementia at the heart of care quality.
Responsive behaviours are experienced by many people who are living with dementia. Non-medication approaches are overwhelmingly the most appropriate and effective means of providing support.
Inadequate and poor quality training, particularly in dementia care, has been a recurring theme in the early weeks of the Royal Commission into Aged Care Quality and Safety.
The design of a building can change the way we engage and interact, move around, and even our mood.
An alarmingly high proportion of people living with dementia in residential care use antipsychotic medications, even though they are of limited benefit for the majority of ‘symptoms’ for which they are prescribed
Today, on World Alzheimer’s Day and in the week when the Royal Commission on Aged Care was announced, we may find ourselves thinking that it is time for things to change in Australian aged care.